Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats

被引:7
作者
Bassant, MH
Poindessous-Jazat, F
Schmidt, BH
机构
[1] INSERM, U159, F-75014 Paris, France
[2] Bayer AG, Clin Pathol & Safety Studies, D-42096 Wuppertal, Germany
关键词
cholinergic system; cholinesterase inhibitor; cerebral metabolism; Alzheimer's disease; nucleus basalis; rat;
D O I
10.1016/S0014-2999(99)00742-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To evaluate the influence of cholinergic projections from the basal forebrain on brain metabolism, we measured the cerebral metabolic rate of glucose (CMR(glu)) after unilateral lesioning of cholinergic basal forebrain neurons with the immunotoxin 192 IgG-saporin. CMR(glu) was determined in 24 cortical and 13 sub-cortical regions using the [C-14]2-deoxy-D-glucose technique of Sokoloff. Average hemispheric CMR(glu) decreased by 7% (P < 0.02) and 5% (P ( 0.05), 7 and 21 days after lesion, respectively. Regional effects were restricted to parietal and retrosplenial cortices, lateral habenula and the basal forebrain. We have previously shown that metrifonate increased CMR(glu) in intact rats. In lesioned rats, metrifonate (80 mg/kg, i.p.) was still active bur the metabolic activation was reduced in terms of both the average hemispheric CMR(glu) and the number of regions significantly affected. Although it is reduced, the sustained effect of metrifonate in lesioned rats makes an argument for the use of this compound as treatment of cholinergic deficit in Alzheimer's disease. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 50 条
[1]   Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats [J].
Bassant, MH ;
JazatPoindessous, F ;
Lamour, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (05) :1014-1025
[2]   TETRAHYDROAMINOACRIDINE AND PHYSOSTIGMINE INCREASE CEREBRAL GLUCOSE-UTILIZATION IN SPECIFIC CORTICAL AND SUBCORTICAL REGIONS IN THE RAT [J].
BASSANT, MH ;
JAZAT, F ;
LAMOUR, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (05) :855-864
[3]   METABOLIC RESPONSE TO TACRINE (THA) AND PHYSOSTIGMINE IN THE AGED RAT-BRAIN [J].
BASSANT, MH ;
JAZATPOINDESSOUS, F .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (06) :1093-1102
[4]   EFFECTS OF METRIFONATE, A LONG-ACTING CHOLINESTERASE INHIBITOR, IN ALZHEIMER-DISEASE - REPORT OF AN OPEN TRIAL [J].
BECKER, RE ;
COLLIVER, J ;
ELBLE, R ;
FELDMAN, E ;
GIACOBINI, E ;
KUMAR, V ;
MARKWELL, S ;
MORIEARTY, P ;
PARKS, R ;
SHILLCUTT, SD ;
UNNI, L ;
VICARI, S ;
WOMACK, C ;
ZEC, RF .
DRUG DEVELOPMENT RESEARCH, 1990, 19 (04) :425-434
[5]   THE FLUORODEOXYGLUCOSE F-18 SCAN IN ALZHEIMERS-DISEASE AND MULTI-INFARCT DEMENTIA [J].
BENSON, DF ;
KUHL, DE ;
HAWKINS, RA ;
PHELPS, ME ;
CUMMINGS, JL ;
TSAI, SY .
ARCHIVES OF NEUROLOGY, 1983, 40 (12) :711-714
[6]   Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: Evaluation of the efficacy/safety profile in rats [J].
Blokland, A ;
Hinz, V ;
Schmidt, BH .
DRUG DEVELOPMENT RESEARCH, 1995, 36 (04) :166-179
[7]   SPECIFICITY OF 192 IGG-SAPORIN FOR NGF RECEPTOR-POSITIVE CHOLINERGIC BASAL FOREBRAIN NEURONS IN THE RAT [J].
BOOK, AA ;
WILEY, RG ;
SCHWEITZER, JB .
BRAIN RESEARCH, 1992, 590 (1-2) :350-355
[8]   Metrifonate treatment of the cognitive deficits of Alzheimer's disease [J].
Cummings, JL ;
Cyrus, PA ;
Bieber, F ;
Mas, J ;
Orazem, J ;
Gulanski, B .
NEUROLOGY, 1998, 50 (05) :1214-1221
[9]   SUSTAINED CORTICAL METABOLIC RESPONSIVITY TO PHYSOSTIGMINE AFTER NUCLEUS BASALIS MAGNOCELLULARIS ABLATION IN RATS [J].
DEMICHELI, E ;
LAMOUR, Y ;
BASSANT, MH ;
SONCRANT, TT .
BRAIN RESEARCH, 1993, 615 (01) :80-86
[10]   Diffuse transmission by acetylcholine in the CNS [J].
Descarries, L ;
Gisiger, V ;
Steriade, M .
PROGRESS IN NEUROBIOLOGY, 1997, 53 (05) :603-625